Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 26: 26-29, 1980;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shull, B. C.
Right arrow Articles by Li, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shull, B. C.
Right arrow Articles by Li, P. K.

Clinical Chemistry, Vol 26, 26-29, Copyright © 1980 by American Association for Clinical Chemistry

Mechanism of interference by hemoglobin in the determination of total bilirubin. II. Method of Jendrassik-Grof

BC Shull, H Lees and PK Li

Oxyhemoglobin in erythrocyte hemolysates interferes with the Jendrassik- Grof assay. Destruction of azobilirubin occurs when oxyhemoglobin is oxidized to methemoglobin during diazotization or to alkaline hematin with addition of alkaline tartrate. The most probable mechanism is by oxidation with an agent such as hydrogen peroxide or a related species resulting from hemoglobin oxidation. Methemoglobin also appears to cause some destruction of azobilirubin during diazotization. Methemoglobin forms during diazotization because of reactions of oxyhemoglobin with both diazo reagent and nitrite ion. Formation of methemoglobin is, therefore, more rapid in the test than in the blank mixture and, under reaction conditions, its absorbance is less than that of oxyhemoglobin. This results in spectral interference when neutral azobilirubin is assayed. Alkaline tartrate abolishes this spectral error by causing rapid formation of alkaline hematin in both test and blank.


The following articles in journals at HighWire Press have cited this article:


Home page
 Ann Clin BiochemHome page
J. M Kirk
Neonatal jaundice: a critical review of the role and practice of bilirubin analysis
Ann Clin Biochem, September 1, 2008; 45(5): 452 - 462.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. F. Lo, B. Jendrzejczak, and B. T. Doumas
Total or Neonatal Bilirubin Assays in the Vitros 5,1 FS: Hemoglobin Interference, Hemolysis, Icterus Index
Clin. Chem., April 1, 2007; 53(4): 799 - 800.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
Z. Ma, T. G. Monk, L. T. Goodnough, A. McClellan, M. Gawryl, T. Clark, P. Moreira, P. E. Keipert, and M. G. Scott
Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests
Clin. Chem., September 1, 1997; 43(9): 1732 - 1737.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the American Association for Clinical Chemistry.